A novel tetranuclear [Pt4(Am4M)4]·16.25H2O (1), where H2Am4M is the thiosemicarbazone ligand (Z)-2-(amino(pyridin-2-yl)methylene)-N-methylhydrazinecarbothioamide, has been synthesized and characterized by using various physico-chemical techniques. X-ray analysis revealed that the Pt(II) complex consists of a neutral tetranuclear [Pt4(Am4M)4] unit and abundant water molecules. The tetranuclear unit is stabilized by strong intramolecular π–π stacking and thus presents a ship-like eight-membered ring [Pt4S4] with four tridentate ligands peripherally coordinated to four Pt(II) ions, constituting a novel type of “well” structure. DNA and protein binding properties of complex 1 have been studied by UV and fluorescence spectroscopic methods. The binding constant (Kb = 3.05 × 106 M−1) and the apparent binding constant (Kapp = 7.732 × 106 M−1) to calf thymus DNA (CT-DNA) were accurately fitted by two respective non-linear equations, suggesting an efficient DNA intercalative binding mode which was confirmed by viscometric experiments. Furthermore, following agarose gel electrophoresis experiments, we observed that the plasmid DNA pUC19 could be completely digested by complex 1, depending on incubation time and concentration, indicating that complex 1 may possess an effective nuclease activity on DNA. Singlet oxygen (1O2) inhibitors showed an inhibitory effect on the cleavage. Fluorescence spectrometry also detected a medium affinity of complex 1 to bovine serum albumin (BSA) at different temperatures, which was tentatively assigned to a static binding mode. All these results suggested that this poly-Pt(II) complex might exhibit biological action as a potential chemotherapy agent.
合成并表征了一种新型四核[Pt4(Am4M)4]·16.25H2O (1),其中H2Am4M是缩
氨基
硫脲配体(Z)-2-(
氨基(
吡啶-2-基)亚甲基)-N-甲基
肼硫代甲酰胺通过使用各种物理
化学技术。 X射线分析表明Pt(II)配合物由中性四核[Pt4(Am4M)4]单元和丰富的
水分子组成。四核单元通过强分子内π-π堆积而稳定,从而呈现出船状八元环[Pt4S4],四个三齿
配体与四个Pt(II)离子外围配位,构成一种新型的“井”结构。复合物 1 的 DNA 和蛋白质结合特性已通过紫外和荧光光谱方法进行了研究。小牛胸腺 DNA (CT-DNA) 的结合常数 (Kb = 3.05 × 106 M−1) 和表观结合常数 (Kapp = 7.732 × 106 M−1) 通过两个各自的非线性方程精确拟合,表明通过粘度实验证实了有效的DNA插入结合模式。此外,在
琼脂糖凝胶电泳实验中,我们观察到质粒DNA pUC19可以被复合物1完全消化,这取决于孵育时间和浓度,表明复合物1可能对DNA具有有效的
核酸酶活性。单线态氧 (1O2)
抑制剂对裂解显示出抑制作用。荧光光谱法还检测到复合物1在不同温度下与
牛血清白蛋白(
BSA)具有中等亲和力,暂时将其指定为静态结合模式。所有这些结果表明,这种聚 Pt(II) 复合物可能表现出作为潜在化疗药物的
生物作用。